Alnylam Pharmaceuticals
ALNY
#637
Rank
ยฃ29.56 B
Marketcap
ยฃ221.42
Share price
-1.02%
Change (1 day)
3.36%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company